Market Research Logo

Immunovia AB (IMMNOV) - Product Pipeline Analysis, 2018 Update

Summary

Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring the therapeutic responsiveness of cancers. Immunovia’s IMMray can also be used for biomarker discovery through its discovery tool for proteome scanning. The company also provides IMMray PanCan-d, a blood-based test for the detection of pancreatic cancer. Its therapeutic areas include cancer and autoimmune diseases such as systemic lupus erythematosus. The company collaborates with various cancer centers for conducting clinical evidence studies. Immunovia is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Immunovia AB
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Immunovia AB Company Overview
Immunovia AB Company Snapshot 5
Immunovia AB Pipeline Products and Ongoing Clinical Trials Overview
Immunovia AB – Pipeline Analysis Overview 7
Immunovia AB - Key Facts 7
Immunovia AB - Major Products and Services 8
Immunovia AB Pipeline Products by Development Stage 9
Immunovia AB Ongoing Clinical Trials by Trial Status 11
Immunovia AB Pipeline Products Overview 12
IMMray - Breast Cancer 12
IMMray - Breast Cancer Product Overview 12
IMMray - Prostate Cancer 13
IMMray - Prostate Cancer Product Overview 13
IMMray PanCan-d 14
IMMray PanCan-d Product Overview 14
IMMray PanCan-d Clinical Trial 15
IMMray PanCan-m Test 16
IMMray PanCan-m Test Product Overview 16
IMMray Primary Sjogren’s Syndrome Assay 17
IMMray Primary Sjogren’s Syndrome Assay Product Overview 17
IMMray Rheumatoid Arthritis Assay 18
IMMray Rheumatoid Arthritis Assay Product Overview 18
IMMray SLE-d Test 19
IMMray SLE-d Test Product Overview 19
IMMray Systemic Vasculitis Assay 20
IMMray Systemic Vasculitis Assay Product Overview 20
Immunovia AB - Key Competitors 21
Immunovia AB - Key Employees 22
Immunovia AB - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Immunovia AB, Recent Developments 24
May 22, 2018: Linkoping University Hospital second Swedish site in largest ever prospective multicenter clinical study for early detection of pancreatic cancer 24
May 04, 2018: Spanish major private hospital joins world’s largest study of familiar risk for pancreatic cancer 24
Apr 27, 2018: Immunovia Interim report, January-March 2018 24
Apr 12, 2018: NYU School of Medicine joins PanFAM-1 prospective study for the early detection of pancreatic cancer in familiar risk groups 25
Feb 16, 2018: Spanish center Santiago de Compostela joins the largest ever prospective study into familial risk of developing pancreatic cancer 25
Feb 15, 2018: Immunovia Full Year report, January-December 2017 26
Feb 08, 2018: Massachusetts General Hospital joins PanFAM-1 Prospective Study for the Early Detection of Pancreatic Cancer in Familiar Risk Groups 26
Jan 11, 2018: Immunovia accelerates pancreas cancer study of new onset diabetics by adding Denmark’s Diabetes Center for Strategic Research-DD2 27
Dec 20, 2017: Sahlgrenska University Hospital first Swedish site in the largest ever prospective clinical study for early detection of pancreatic cancer 27
Dec 18, 2017: Immunovia Initiates the World's Largest Study of New-Onset Diabetic Patients in a Prospective Pancreas Cancer Study Supported by Swelife 28
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Immunovia AB Pipeline Products and Ongoing Clinical Trials Overview 5
Immunovia AB Pipeline Products by Equipment Type 6
Immunovia AB Pipeline Products by Indication 6
Immunovia AB Ongoing Clinical Trials by Trial Status 6
Immunovia AB, Key Facts 7
Immunovia AB, Major Products and Services 8
Immunovia AB Number of Pipeline Products by Development Stage 9
Immunovia AB Pipeline Products Summary by Development Stage 10
Immunovia AB Ongoing Clinical Trials by Trial Status 11
Immunovia AB Ongoing Clinical Trials Summary 11
IMMray - Breast Cancer - Product Status 12
IMMray - Breast Cancer - Product Description 12
IMMray - Prostate Cancer - Product Status 13
IMMray - Prostate Cancer - Product Description 13
IMMray PanCan-d - Product Status 14
IMMray PanCan-d - Product Description 14
IMMray PanCan-d - A Prospective Evaluation of IMMray PanCan-d Biomarker Signature Assay in Subjects with New Onset Diabetes (NOD) 15
IMMray PanCan-d - IMMray PanCan-d Utility in Patients with Abdominal Symptoms Attending Secondary Care Centres 15
IMMray PanCan-d - Validation of Early Detection Blood Test for Pancreatic Cancer 15
IMMray PanCan-m Test - Product Status 16
IMMray PanCan-m Test - Product Description 16
IMMray Primary Sjogren’s Syndrome Assay - Product Status 17
IMMray Primary Sjogren’s Syndrome Assay - Product Description 17
IMMray Rheumatoid Arthritis Assay - Product Status 18
IMMray Rheumatoid Arthritis Assay - Product Description 18
IMMray SLE-d Test - Product Status 19
IMMray SLE-d Test - Product Description 19
IMMray Systemic Vasculitis Assay - Product Status 20
IMMray Systemic Vasculitis Assay - Product Description 20
Immunovia AB, Key Employees 22
Immunovia AB, Subsidiaries 23
Glossary 31
List of Figures
Immunovia AB Pipeline Products by Equipment Type 6
Immunovia AB Pipeline Products by Development Stage 9
Immunovia AB Ongoing Clinical Trials by Trial Status 11

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report